Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2005 08:58 ET | Source: Crucell N.V.

AFM Completes Investigation into Exercising of Options by Crucell Management

LEIDEN, Netherlands, April 1, 2005 (PRIMEZONE) -- The Netherlands Authority for the Financial Markets (AFM) has notified Crucell that its investigation into the exercise of options and the subsequent...
March 31, 2005 05:06 ET | Source: Crucell N.V.

Crucell N.V.: Staf Van Reet to lead Galapagos Corporate Development

LEIDEN, The Netherlands, March 31, 2005 (PRIMEZONE) -- Galapagos, a genomics-based drug discovery company, announces that it has appointed Staf Van Reet as VP Corporate Development. Dr. Van Reet will...
March 30, 2005 01:31 ET | Source: Crucell N.V.

Crucell Announces PER.C6 Licensing Agreement with Vascular Biogenics

LEIDEN, The Netherlands, March 30, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a PER.C6(R) research license agreement...
March 23, 2005 02:06 ET | Source: Crucell N.V.

Crucell and DSM Announce PER.C6 Licensing Agreement with Mitsubishi Pharma for Protein Production

LEIDEN, The Netherlands, March 23, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that DSM...
March 22, 2005 08:18 ET | Source: Crucell N.V.

Crucell Signs Commercial PER.C6 License Agreement with SingVax for Vaccines against Japanese Encephalitis

LEIDEN, Netherlands, March 22, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Nasdaq:CRXL) (Euronext:CRXL) today announced the signing of a commercial PER.C6(R) license agreement with...
March 18, 2005 02:07 ET | Source: Crucell N.V.

Crucell Secures Exclusive Patent License from NIH to Commercialize Ebola Vaccines

LEIDEN, Netherlands, March 18, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has obtained an exclusive license to certain patents...
March 17, 2005 02:07 ET | Source: Crucell N.V.

Crucell and NIH extend Ebola Vaccine Agreement

LEIDEN, The Netherlands, March 17, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has extended its Cooperative Research and...
March 10, 2005 02:11 ET | Source: Crucell N.V.

Crucell and DSM Announce PER.C6 Licensing Agreement with JCR Pharmaceuticals for Protein Production

LEIDEN, The Netherlands, March 10, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they...
March 09, 2005 03:36 ET | Source: Crucell N.V.

Crucell N.V.: Galapagos is Considering a Stock Exchange Listing

LEIDEN, The Netherlands, March 9, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) announced today that Galapagos Genomics N.V. is considering a Euronext...
March 09, 2005 03:18 ET | Source: Crucell N.V.

Galapagos Considering a Stock Exchange Listing

LEIDEN, The Netherlands, March 9, 2005 (PRIMEZONE) -- Galapagos Genomics NV, a genomics-based drug discovery company, announces that it is considering a Euronext stock exchange listing in 2005. The...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right